HK1220352A1 - 和神經變性疾病的治療 - Google Patents
和神經變性疾病的治療Info
- Publication number
- HK1220352A1 HK1220352A1 HK16107602.7A HK16107602A HK1220352A1 HK 1220352 A1 HK1220352 A1 HK 1220352A1 HK 16107602 A HK16107602 A HK 16107602A HK 1220352 A1 HK1220352 A1 HK 1220352A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- neurodegenerative diseases
- neurodegenerative
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361767962P | 2013-02-22 | 2013-02-22 | |
FI20135169 | 2013-02-22 | ||
PCT/EP2014/053414 WO2014128254A1 (en) | 2013-02-22 | 2014-02-21 | Il-33 and treatment of neurodegenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220352A1 true HK1220352A1 (zh) | 2017-05-05 |
Family
ID=51390519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16107602.7A HK1220352A1 (zh) | 2013-02-22 | 2016-06-29 | 和神經變性疾病的治療 |
Country Status (4)
Country | Link |
---|---|
US (1) | US9867867B2 (zh) |
EP (1) | EP2958583B1 (zh) |
HK (1) | HK1220352A1 (zh) |
WO (1) | WO2014128254A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3783023A1 (en) | 2014-11-10 | 2021-02-24 | H. Hoffnabb-La Roche Ag | Anti-interleukin-33 antibodies and uses thereof |
JP7231326B2 (ja) | 2014-11-10 | 2023-03-01 | ジェネンテック, インコーポレイテッド | Il-33媒介性障害のための治療及び診断方法 |
US10813979B2 (en) * | 2015-07-10 | 2020-10-27 | The Hong Kong University Of Science And Technology | Methods and compositions for treating neurodegenerative and neuroinflammatory conditions |
WO2017202814A1 (en) * | 2016-05-24 | 2017-11-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of neuropathological disorders characterized by a loss of cortical neurons |
CN106511972B (zh) * | 2016-11-17 | 2019-11-22 | 苏州大学 | 白介素33在制备治疗癫痫病药物中的应用 |
WO2018154187A1 (en) * | 2017-02-27 | 2018-08-30 | University Of Eastern Finland | Il-13 and treatment of diseases or defects of the central nervous system |
KR20210077634A (ko) * | 2019-12-17 | 2021-06-25 | 코아스템(주) | 인간 만능 줄기세포로부터 3d 오가노이드를 이용하여 미세교세포를 다량 확보하는 미세교세포의 분화방법 |
EP4118114A1 (en) | 2020-03-13 | 2023-01-18 | Genentech, Inc. | Anti-interleukin-33 antibodies and uses thereof |
KR20240004214A (ko) * | 2020-11-04 | 2024-01-11 | 이뮨 시스템 키 엘티디. | 신경변성 질환의 치료 및 예방에 사용하기 위한 폴리펩티드 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
US8147817B2 (en) * | 2006-05-04 | 2012-04-03 | The Brigham And Women's Hospital, Inc. | IL-33 in the treatment and diagnosis of diseases and disorders |
EP2211905A1 (en) | 2007-10-26 | 2010-08-04 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Inhibitors of caspase i-dependent cytokines in the treatment of neurodegenerative disorders |
US20150306139A1 (en) | 2011-04-21 | 2015-10-29 | Jeffrey Ravetch | Anti-inflammatory agents |
-
2014
- 2014-02-21 US US14/769,150 patent/US9867867B2/en active Active
- 2014-02-21 EP EP14705537.0A patent/EP2958583B1/en active Active
- 2014-02-21 WO PCT/EP2014/053414 patent/WO2014128254A1/en active Application Filing
-
2016
- 2016-06-29 HK HK16107602.7A patent/HK1220352A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US9867867B2 (en) | 2018-01-16 |
EP2958583A1 (en) | 2015-12-30 |
US20160000876A1 (en) | 2016-01-07 |
EP2958583B1 (en) | 2018-04-11 |
WO2014128254A1 (en) | 2014-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273688A (en) | Evaluation and treatment of bradykinin-mediated disorders | |
HK1217439A1 (zh) | 與毒性醛相關的疾病和治療 | |
IL239368A0 (en) | Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system | |
HK1222552A1 (zh) | 索布替羅用於治療髓鞘形成疾病 | |
GB201320723D0 (en) | Composition and methods of treatment | |
EP2953950A4 (en) | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | |
HK1220352A1 (zh) | 和神經變性疾病的治療 | |
EP2999474A4 (en) | THERAPEUTIC AND METHOD OF USE | |
FI3626270T3 (fi) | Sydän- ja verisuonitautien hoito | |
EP2943189A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEMYELINATING DISEASES | |
EP3068492A4 (en) | Neurodegenerative disorders and methods of treatment and diagnosis thereof | |
IL234726A0 (en) | Catheter and its manufacturing method | |
ZA201603117B (en) | Withanolides useful for the treatment of neurodegenerative diseases | |
EP2964227A4 (en) | TREATMENT AND PROPHYLAXIS OF RENAL DISEASES | |
GB201607581D0 (en) | Treatment of cancer | |
HK1218882A1 (zh) | 用於治療神經退化疾病和其它疾病的組合治療劑和方法 | |
HK1220127A1 (zh) | 自身免疫性疾病的治療 | |
EP3089984A4 (en) | NOVEL COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES | |
GB201317373D0 (en) | Treatment and prevention of cancer | |
GB201301685D0 (en) | Diagnosis and treatment of cancer | |
GB201322347D0 (en) | Treatment of cancer | |
GB201318742D0 (en) | Treatment of cancer | |
GB201308529D0 (en) | Treatment of cancer | |
GB201305020D0 (en) | Treatment of cancer |